Skip to main content

Table 5 Comparison between group I (control group) and group II (case group) regarding levels of hemoglobin, AST, ALT, albumin, total bilirubin, INR, platelets, and creatinine 8 weeks after treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

  Group I Group II Test value p value
Hemoglobin (gm/dl) Mean ± SD 12.53 ± 1.35 9.43 ± 1.75 9.763 0.001
Range 9.8–15.5 6.4–13
AST (U/L) Normal 50 (100%) 46 (100%) 0.930 0.335
High 0 (0%) 0 (0%)
ALT (U/L) Normal 49 (98%) 46 (100%) 0.930 0.335
High 1(2%) 0(0%)
Albumin (gm/dl) Mean ± SD 4.18 ± 0.39 3.97 ± 0.54 2.202 0.030
Range 2.6–5.1 2–5.4
Bilirubin (mg/dl) Mean ± SD 0.90 ± 0.42 0.62 ± 0.24 3.848 0.001
Range 0.3–2.08 0.1–1.39
INR Mean ± SD 1.11 ± 0.16 1.10 ± 0.13 0.618 0.538
Range 0.95–2 0.67–1.4
Platelets (103/mm3) Mean ± SD 234.44 ± 65.96 225.95 ± 68.82 0.610 0.543
Range 135–439 105–400
Creatinine (mg/dl) Median (IQR) 0.9 (0.8–1) 7 (5.9–9.1) − 8.310 0.001
Range 0.6–1.2 3.5 –13.8